Ceo-two Suppository
NDC Package 0283-1023-36

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Ceo-two (laxative) suppositories is adults and children 12 years of age and over:  rectal dosage is one suppository containing 0.6 gram of sodium bicarbonate and 0.9 gram of potassium bitartrate in a single daily doseChildren under 12 years of age:  consult a doctorDetach one suppository from the strip; remove plastic wrapper.  Moisten suppository by placing it under a water tap for 30 seconds, or in a cup of water for at least 10 seconds, before insertion.  Insert rectally, bulb shape first, past largest diameter of suppository.  Retain suppository as long as possible (usually 10 to 30 minutes) before defecating. This formulation utilizes a suppository delivery system. Marketed by Beutlich Pharmaceuticals, Llc, this product is identified by NDC 0283-1023 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
0283-1023-36
Package Description
6 DOSE PACK in 1 BOX / 5.7 g in 1 DOSE PACK (0283-1023-00)
Product Code
0283-1023
11-Digit Billing Format
00283102336
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 636185 - potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM Rectal Suppository
  • RxCUI: 636185 - potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository
  • RxCUI: 636185 - K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository
  • RxCUI: 636185 - Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository
  • RxCUI: 636188 - CEO-TWO 0.9 GM / 0.6 GM Rectal Suppository

Clinical Specifications

Proprietary Name
Ceo-two
Non-Proprietary Name
Laxative
Substance Name
Potassium Bitartrate; Sodium Bicarbonate
Dosage Form
Suppository - A solid body of various weights and shapes, adapted for introduction into the rectal orifice of the human body; they usually melt, soften, or dissolve at body temperature.
Administration Route
Rectal - Administration to the rectum.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults and children 12 years of age and over:  rectal dosage is one suppository containing 0.6 gram of sodium bicarbonate and 0.9 gram of potassium bitartrate in a single daily doseChildren under 12 years of age:  consult a doctorDetach one suppository from the strip; remove plastic wrapper.  Moisten suppository by placing it under a water tap for 30 seconds, or in a cup of water for at least 10 seconds, before insertion.  Insert rectally, bulb shape first, past largest diameter of suppository.  Retain suppository as long as possible (usually 10 to 30 minutes) before defecating.

Regulatory & Marketing

Labeler Name
Beutlich Pharmaceuticals, Llc
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-15-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0283-1023). Click a package code to view its specific billing and regulatory data.

0283-1023-02
2 DOSE PACK in 1 BOX / 5.7 g in 1 DOSE PACK (0283-1023-00)
0283-1023-54
54 DOSE PACK in 1 BOX / 5.7 g in 1 DOSE PACK (0283-1023-00)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0283-1023-36 identifies a specific commercial package of 6 dose pack in 1 box / 5.7 g in 1 dose pack (0283-1023-00) of Ceo-two, a human over the counter drug labeled by Beutlich Pharmaceuticals, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This suppository is formulated for rectal use and contains potassium bitartrate; sodium bicarbonate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Beutlich Pharmaceuticals, Llc on October 15, 2023. The current certification is valid through December 31, 2026.

How is this Beutlich Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00283102336. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0283-1023-36
11-Digit CMS (5-4-2)
00283-1023-36

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.